![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](bg2218contents.gif)
Acta Cryst. (2008). E64, m1612-m1613 [ doi:10.1107/S1600536808038786 ]
-2-(3-phenoxyphenyl)propionato-
2O:O']bis[(dimethylformamide-
O)copper(II)]Abstract: The title compound, [Cu2(C15H13O3)4(C3H7NO)2], is formed by the chelate coordination of four racemic fenoprofenate (fenoprofenate is 2,3-phenoxyphenyl propionate) anions and two dimethylformamide molecules to two copper(II) ions, building a paddle-wheel dinuclear molecule. The distorted square-pyramidal coordination of each CuII atom is made up of four O atoms of the four fenoprofenate units and another O atom from a dimethylformamide molecule. The two enantiomeric forms of the fenoprofenate anions are present in the complex, in an optically inactive centrosymmetric arrangement.
Online 26 November 2008
Copyright © International Union of Crystallography
IUCr Webmaster